M1300 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) billable
M1301 Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) billable
M1302 Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed billable
M1303 Hospice services provided to patient any time during the measurement period billable
M1304 Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period billable
M1305 Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period billable
M1306 Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period billable
M1307 Documentation stating the patient has received or is currently receiving palliative or hospice care billable
M1308 Influenza immunization was not administered, reason not given billable
M1309 Palliative care services provided to patient any time during the measurement period billable
M1310 Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user billable
M1311 Anaphylaxis due to the vaccine on or before the date of the encounter billable
M1312 Patient not screened for tobacco use billable
M1313 Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period billable
M1314 Bmi not documented and no reason is given billable
M1315 Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified billable
M1317 Patients who are counseled on connection with a csp and explicitly opt out billable
M1318 Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp billable
M1319 Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening billable
M1320 Patients who screened positive for at least 1 of the 5 hrsns billable
M1321 Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg billable
M1322 Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye billable
M1323 Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented billable
M1324 Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant) billable
M1325 Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment) billable
M1326 Patients with a diagnosis of hypotony billable
M1327 Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks billable
M1328 Patients with a diagnosis of acute vitreous hemorrhage billable
M1329 Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter billable
M1330 Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up) billable
M1331 Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam billable
M1332 Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks billable
M1334 Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter billable
M1335 Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up) billable
M1336 Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks billable
M1338 Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period billable
M1339 Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period billable
M1340 Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period billable
M1341 Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period billable
M1342 Patients who died during the performance period billable
M1343 Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses billable
M1344 Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score billable
M1345 Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score billable
M1346 Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period billable
M1347 Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing) billable
M1348 Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent) billable
M1349 Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period billable
M1350 Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter billable
M1351 Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation billable
M1352 Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment billable
M1353 Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter billable
M1354 Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation billable
M1355 Suicide risk based on their clinician's evaluation or a clinician-rated tool billable
M1356 Patients who died during the measurement period billable
M1357 Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment billable
M1358 Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment billable
M1359 Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained billable
M1360 Suicidal ideation and/or behavior symptoms based on the c-ssrs billable
M1361 Suicide risk based on their clinician's evaluation or a clinician-rated tool billable
M1362 Patients who died during the measurement period billable
M1363 Patients who did not have a follow-up assessment within 120 days of the index assessment billable
M1364 Calculated 10-year ascvd risk score of >= 20 percent during the performance period billable
M1365 Patient encounter during the performance period with hospice and palliative care specialty code 17 billable
M1366 Focusing on women's health mips value pathway billable
M1367 Quality care for the treatment of ear, nose, and throat disorders mips value pathway billable
M1368 Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway billable
M1369 Quality care in mental health and substance use disorders mips value pathway billable
M1370 Rehabilitative support for musculoskeletal care mips value pathway billable
M1371 Most recent glycemic status assessment (hba1c or gmi) level < 7.0% billable
M1372 Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0% billable
M1373 Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0% billable
M1374 An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period billable
M1375 An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period billable
M1376 An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period billable
M1377 Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient billable
M1378 Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons) billable
M1379 A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified billable
M1380 Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note" billable
M1381 Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure billable
M1382 Patient encounter during the performance period with place of service code 11 billable
M1384 Patients who died during the performance period billable
M1385 Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up billable
M1386 Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period billable
M1387 Patients who died during the performance period billable
M1388 Patients with documentation of an exam performed for recurrence of melanoma billable
M1390 Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period billable
M1391 All patients who were diagnosed with recurrent melanoma during the current performance period billable
M1392 Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented) billable
M1393 Patients who were not diagnosed with recurrent melanoma during the current performance period billable